CIK 0001889109 · Large accelerated filer
BELITE BIO, INC
Sign in to watch- Ticker
- BLTE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 858-246-6240
- Business address
- 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
- Former names
- BELITE BIO, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $31,968,735
- in 3 filings, $32.0M under 10b5-1 plans
Net −$31,968,735. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-29 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −278 | $154.58 | $43K | 6,388 |
| 2026-04-29 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −259 | $155.52 | $40K | 6,129 |
| 2026-04-29 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −339 | $156.43 | $53K | 5,790 |
| 2026-04-29 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −102 | $157.39 | $16K | 5,688 |
| 2026-04-29 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −22 | $158.19 | $3K | 5,666 |
| 2026-04-28 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −12 | $154.65 | $2K | 7,654 |
| 2026-04-28 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −8 | $155.36 | $1K | 7,646 |
| 2026-04-28 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −53 | $156.61 | $8K | 7,593 |
| 2026-04-28 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −222 | $157.49 | $35K | 7,371 |
| 2026-04-28 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −62 | $158.71 | $10K | 7,309 |
| 2026-04-28 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −380 | $159.42 | $61K | 6,929 |
| 2026-04-28 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −120 | $160.27 | $19K | 6,809 |
| 2026-04-28 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −89 | $161.72 | $14K | 6,720 |
| 2026-04-28 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −54 | $162.14 | $9K | 6,666 |
| 2026-04-27 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −44 | $160.83 | $7K | 8,622 |
| 2026-04-27 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −280 | $161.62 | $45K | 8,342 |
| 2026-04-27 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −231 | $162.38 | $38K | 8,111 |
| 2026-04-27 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −409 | $163.56 | $67K | 7,702 |
| 2026-04-27 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −36 | $164.07 | $6K | 7,666 |
| 2026-04-24 | MATA NATHAN L. Chief Scientific Officer | Sale 10b5-1 | −74 | $157.86 | $12K | 9,592 |
Page 6 of 10 · 186 trades